Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ZBH

Can Market Sentiment Sustain ZBH's Price Surge Today?

Rocketing to a price of $83.39 during today's evening trading session, shares of Zimmer Biomet are still -15.36% below their average target price of $98.52. Could there be more upside potential for the stock? Analysts are giving ZBH an average rating of hold and target prices ranging from $83.0 to $130.0 dollars per share.

Zimmer Biomet's short interest can give us an idea of what future price movements the market expects from the stock. The short interest is the percentage of shares that are tied up in short positions, which will provide gains to the investor only if the stock price falls. The stock's short interest is 6.8% which seems to indicate a mixed sentiment on ZBH

When a stock is sold short, it means an investor has borrowed shares of the stock from their broker, and then sold them at the going market price. The investor hopes for the price to decline, so that they might buy those shares back at a lower price in the future. Once they do, they can return the borrowed shares to their broker, and keep the profit they made on the transaction.

One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of Zimmer Biomet, institutional investors own 105.5% of the shares. This would indicate a positive sentiment towards the stock among institutions. What does this really tell us?

Institutional investors such as hedge funds, investment firms, and wealth managers devote significant resources to identifying good investments. If they have decided to invest in ZBH, it probably means they believe it is a solid investment choice. But it could also mean they are buying up shares in an effort to acquire the company or get seats on the board of directors. Also bear in mind that institutions are fallible (just maybe not quite as fallible as the average retail investor), so they may simply be wrong when they think they've found a good stock.

Overall, there is mixed market sentiment on Zimmer Biomet because its an analyst consensus of some upside potential, a hold rating, an average amount of shares sold short, and a significant number of institutional investors. Warren Buffett famously said that in the short term, markets are voting mechanisms, but in the long term, they are weighing mechanisms. This means that long term investors should be aware of a stock's fundamentals before committing.

Buffett was one of the fist investors to focus on free cash flow as a yardstick for a company's health. Here are ZBH's recent cash flows:

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2025 1,697,100 224,500 1,472,600 13.66
2024 1,499,400 203,800 1,295,600 0.4
2023 1,581,600 291,100 1,290,500 10.46
2022 1,356,200 187,900 1,168,300 -13.82
2021 1,499,200 143,600 1,355,600 24.07
2020 1,204,500 111,900 1,092,600
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS